NEPHROCARE — Nephro Care India Income Statement
0.000.00%
- IN₹2.06bn
- IN₹1.86bn
- IN₹460.31m
Annual income statement for Nephro Care India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18.2 | 34.2 | 171 | 272 | 460 |
Cost of Revenue | |||||
Gross Profit | 5.86 | 19.4 | 121 | 181 | 330 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.8 | 34.1 | 145 | 213 | 426 |
Operating Profit | 1.42 | 0.142 | 26.4 | 59.5 | 34.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.18 | 0.002 | 25.8 | 62.2 | 48.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.887 | -0.098 | 23.7 | 45 | 36.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.887 | -0.098 | 23.7 | 45 | 36.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.887 | -0.098 | 23.7 | 44.1 | 36.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.054 | -0.006 | 1.44 | 2.68 | 2.38 |
Dividends per Share |